(Adds analyst comment in bullet 4) By Sahil Pandey Nov 10 (Reuters) – Mirum Pharmaceuticals said on Tuesday its experimental treatment for hepatitis delta, a serious liver infection, led to reduced
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
VIDEO SHOWS: BUSES TRANSPORTING THE IRANIAN NATIONAL SOCCER TEAM/ CHILDREN WAVING IRAQI AND IRANIAN FLAGS…
RUSSIAN DIESEL IS ON THE WATER AND 'HEADED TO MARKET' WHICH WILL EASE FUEL PRICES…
By Echo Wang, Manya Saini and Arasu Kannagi Basil Nov 10 (Reuters) - Anthropic's blockbuster…
By Echo Wang, Manya Saini and Arasu Kannagi Basil Nov 10 (Reuters) - Anthropic's blockbuster…
Nov 10 (Reuters) - Microsoft overtook Nvidia as the world's most valuable company on Tuesday,…
Nov 10 (Reuters) - Construcciones y Auxiliar de Ferrocarriles, S.A.: * MAINTAINS ITS OUTLOOK FOR…